Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer

Abstract Bladder cancer ranks as the 10th most common cancer worldwide, with deteriorating prognosis as the disease advances. While immune checkpoint inhibitors (ICIs) have shown promise in clinical therapy in both operable and advanced bladder cancer, identifying patients who will respond is challe...

詳細記述

書誌詳細

出版年:	Molecular Cancer
主要な著者:	Tianlei Xie, Shan Peng, Shujun Liu, Minghao Zheng, Wenli Diao, Meng Ding, Yao Fu, Hongqian Guo, Wei Zhao, Junlong Zhuang
フォーマット:	論文
言語:	英語
出版事項:	BMC 2024-02-01
主題:	Bladder cancer Prognostic signature Immunotherapy Anoikis Tumor immune microenvironment
オンライン･アクセス:	https://doi.org/10.1186/s12943-024-01945-9